Catalyst Wire Dossier Catalyst Wire Dossier

Enclomiphene

enclomiphene · Repros Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Enclomiphene, covering 2019-06-14 to 2019-06-14. Get the full timeline:

Most recent: Clinical Trial Update: A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene [Phase 2]

See pricing